New stability indicating RP-HPLC-PDA method for determination of mifepristone in bulk and tablet formulation

New stability indicating RP-HPLC-PDA method for determination of mifepristone in bulk and tablet formulation

Abstract Background Mifepristone is progestational and glucocorticoid hormone antagonist. The objective of this study is to develop simple and economical stability indicating RP-HPLC method for the determination of mifepristone in bulk and tablet formulation. Result The chromatographic separation wa...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Mohammad Mojeeb Gulzar Khan, Mohammad Faizan Saadique Deshmukh, Sandip Dinkar Firke, Abdul Talib Abdul Wahab, Mohan Ganpatrao Kalaskar, Atul Arun Shirkhedkar
Format: article
Langue:EN
Publié: SpringerOpen 2021
Sujets:
Mifepristone
Stability indicating RP-HPLC method
Forced degradation studies
Therapeutics. Pharmacology
RM1-950
Pharmacy and materia medica
RS1-441
Accès en ligne:https://doaj.org/article/95aae83e816140e39d43cd909b62b8d0
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/95aae83e816140e39d43cd909b62b8d0

Documents similaires